Wells Trecaso Financial Group, LLC Merck & Co., Inc. Transaction History

Wells Trecaso Financial Group, LLC

$283 Million
Q1 2024

A detailed history of Wells Trecaso Financial Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Wells Trecaso Financial Group, LLC holds 5,626 shares of MRK stock, worth $704,712. This represents 0.26% of its overall portfolio holdings.

Number of Shares

5,626

Previous 5,826 3.43%

Holding current value

$704,712

Previous $635,000 16.85%

% of portfolio

0.26%

Previous 0.26%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$113.24 - $131.95 $22,648 - $26,389	-200 Reduced 3.43%	5,626 $742,000
Q1 2023 Apr 20, 2023	SELL	$102.94 - $114.86 $25,735 - $28,715	-250 Reduced 4.11%	5,826 $619,000
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $11,804 - $15,134	-135 Reduced 2.17%	6,076 $0
Q3 2022 Oct 24, 2022	SELL	$84.53 - $94.96 $3,550 - $3,988	-42 Reduced 0.67%	6,211 $535,000
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $5,426 - $6,151	-65 Reduced 1.03%	6,253 $570,000

Q1 2022 Apr 14, 2022	BUY	$73.51 - $82.4 $1,837 - $2,060	25 Added 0.4%	6,318 $518,000
Q4 2021 Jan 31, 2022	SELL	$72.28 - $90.54 $3,614 - $4,527	-50 Reduced 0.79%	6,293 $482,000
Q3 2021 Nov 09, 2021	SELL	$71.68 - $78.83 $7,168 - $7,883	-100 Reduced 1.55%	6,343 $476,000
Q1 2021 Apr 19, 2021	BUY	$68.86 - $81.11 $1,032 - $1,216	15 Added 0.23%	6,443 $497,000
Q4 2020 Feb 04, 2021	BUY	$71.77 - $79.65 $8,827 - $9,796	123 Added 1.95%	6,428 $526,000
Q3 2020 Oct 26, 2020	BUY	$73.18 - $82.95 $3,659 - $4,147	50 Added 0.8%	6,305 $523,000
Q2 2020 Jul 21, 2020	SELL	$70.42 - $80.13 $16,196 - $18,429	-230 Reduced 3.55%	6,255 $484,000
Q1 2020 Apr 17, 2020	SELL	$63.36 - $87.82 $57,974 - $80,355	-915 Reduced 12.36%	6,485 $499,000
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $35,454 - $40,005	-457 Reduced 5.82%	7,400 $673,000
Q3 2019 Oct 16, 2019	SELL	$76.08 - $82.93 $6,542 - $7,131	-86 Reduced 1.08%	7,857 $661,000
Q2 2019 Jul 22, 2019	SELL	$69.84 - $81.59 $28,424 - $33,207	-407 Reduced 4.87%	7,943 $666,000
Q1 2019 Apr 18, 2019	BUY	$69.58 - $79.36 $13,568 - $15,475	195 Added 2.39%	8,350 $694,000
Q4 2018 Jan 28, 2019	BUY	$65.24 - $75.71 $235,842 - $273,691	3,615 Added 79.63%	8,155 $623,000
Q3 2018 Oct 22, 2018	BUY	$57.69 - $67.84 $17,307 - $20,352	300 Added 7.08%	4,540 $322,000
Q2 2018 Jul 25, 2018	BUY	$50.83 - $59.72 $16,773 - $19,707	330 Added 8.44%	4,240 $257,000
Q1 2018 Apr 23, 2018	SELL	$50.96 - $59.23 $3,312 - $3,849	-65 Reduced 1.64%	3,910 $213,000
Q4 2017 Apr 23, 2018	BUY	$51.62 - $61.64 $205,189 - $245,019	3,975	3,975 $224,000

Others Institutions Holding MRK

# of Institutions

3,773

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $317B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.

Account

Wells Trecaso Financial Group, LLC Merck & Co., Inc. Transaction History